Progenity, Inc. Company Profile

04:28 EDT 26th September 2018 | BioPortfolio

News Articles [1 Associated News Articles listed on BioPortfolio]

Macrolide Pharmaceuticals Expands Leadership and Strengthens Expertise in Drug Development, Clinical Strategy, Finance and Business Development

Macrolide Pharmaceuticals, which is currently developing novel therapies to fight serious infections, today announced a leadership expansion that adds significant expe...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

FMR1 premutation frequency in a large, ethnically diverse population referred for carrier testing.

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and is caused by an expansion of cytosine-guanine-guanine (CGG) repeats in the FMR1 gene. Female premutation alle...

Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Progenity Inc.

Progenity is a biotechnology company with a market-leading presence in Women’s Health molecular testing and a pipeline of proprietary tests and therapeutic applications under...

Progenity, Inc.

More Information about "Progenity, Inc." on BioPortfolio

We have published hundreds of Progenity, Inc. news stories on BioPortfolio along with dozens of Progenity, Inc. Clinical Trials and PubMed Articles about Progenity, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Progenity, Inc. Companies in our database. You can also find out about relevant Progenity, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record